Immunotherapy of cancer through targeting of the p53 tumor antigen

Related Experiment Video

Updated: Sep 28, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Sander Zwaveling1, Sjoerd H Van der Burg, Anand G Menon

  • 1Leiden University Medical Center, Department of Immunohematology and Blood Transfusion, Tumor Immunology Group, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

Archivum Immunologiae Et Therapiae Experimentalis
|November 29, 2002
PubMed

Insights

The p53 tumor suppressor protein is a promising target for cancer immunotherapy due to its increased expression in many cancers. However, targeting this auto-antigen requires careful consideration of immune tolerance and potential autoimmune side effects.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • The p53 tumor suppressor protein is upregulated in numerous human cancers.
  • This makes p53 an attractive target for T cell-based cancer immunotherapies.

Purpose of the Study:

  • To evaluate the potential of targeting the p53 tumor suppressor protein for cancer immunotherapy.
  • To identify challenges associated with using p53 as a therapeutic target.

Main Methods:

  • Review of existing literature on p53 expression in cancer.
  • Analysis of immunological tolerance mechanisms.
  • Assessment of potential autoimmune risks.

Main Results:

  • p53's elevated expression across various cancers presents a viable immunotherapy target.
  • Exploiting p53 necessitates addressing immunological tolerance.
  • Autoimmune pathology is a significant concern.

Conclusions:

  • Targeting p53 for cancer immunotherapy is promising but complex.
  • Careful management of immune responses is crucial to mitigate risks.
  • Further research is needed to balance efficacy and safety.

More Related Videos

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination05:39

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Published on: February 9, 2021

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...